Filing metadata

Accession number
0001127602-24-017121
Form type
Form 4
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
May 31, 2024
Reporting period
May 30, 2024
Description
Insider transaction

Explore SEC Filings Hub